January 2023 in “Annals of dermatology/Annals of Dermatology”
This study found that overexpression of miR-1246 in peripheral CD4+ Tcells can reduce markers associated with inflammation and Tcell activation in severe active alopecia areata, suggesting potential therapeutic benefits.
1 citations
,
May 2023 in “The Journal of Immunology”
In this animal study, researchers discovered that CD4Tcells from mice with alopecia areata can induce the disease more efficiently than those from unaffected mice, likely by supporting CD8 Tcell activation and hair follicle attack.
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.